VRCA: Prakiraan wutah bathi saben saham kanggo taun ngarep verrica.com

Logo perusahaan publik Verrica Pharmaceuticals Inc (VRCA)

Verrica Pharmaceuticals revenues are based on the demand for dermatological products and physician recognition of the therapy. The projection of the company's EPS for the next year visualizes these expectations, where the 22.10 metric determines this level. Drug production has been fully outsourced to third-party contractors, creating a dependency on their quality. The success of Ycanth solidified its leadership in the treatment of molluscum contagiosum following FDA approval.

VRCA: Prakiraan wutah bathi resik saben saham ing taun ngarep Verrica 04.07.2022 - 18.11.2026

Verrica Pharmaceuticals Inc - rincian analitis lan metrik utama (VRCA)

Analisis wiwitan perusahaan:Verrica Pharmaceuticals Inc, VRCA
Barang utama Verrica Pharmaceuticals Inc.

The monopoly status of the drug Inertia in dermatology creates a long-term foundation for high business margins at Verrica Pharmaceuticals (VRCA). This indicator measures the consensus forecast for earnings per share changes, reflecting the reallocation of institutional investor capital based on new data. A positive trend in the expected growth of net earnings per share for next year confirms market confidence in the successful commercialization of the product.

Analisis perusahaan pesaing

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Krystal Biotech|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep APGE (Apogee Therapeutics)|Prakiraan wutah bathi kanggo taun ngarep ARQT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep VCEL (Vericel)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oruka Corp ORKA|Prakiraan wutah bathi kanggo taun ngarep Sanara MedTech Inc. SMTI|DBVT: Prakiraan wutah bathi saben saham kanggo taun ngarep|SLSN: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Journey Medical Corp. (DERM) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|FBRX: Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep empro.my|SLGL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep AXIL|Prakiraan wutah bathi kanggo taun ngarep medicuspharma.com (MDCX)|Prakiraan wutah bathi kanggo taun ngarep HOTH (Hoth Therapeutics, Inc.)|BFRI: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|VYNE Therapeutics Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep SNOA|QNRX: Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AZTR|DRMA (Dermata Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ELAB|Prakiraan wutah bathi kanggo taun ngarep RVNC